← Browse by Condition
Medical Condition
hepatic impairment
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1
NCT06962332 Phase 1
Recruiting
Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)
Enrollment
20 pts
Location
United States
Sponsor
Exelixis
NCT07457229 Phase 1
Recruiting
Phase 1 Open-Label Study of Radiprodil Pharmacokinetics, Safety, and Tolerability in Hepatically Impaired Participants
Enrollment
40 pts
Location
United States
Sponsor
GRIN Therapeutics, Inc.
NCT07269301 Phase 1
Recruiting
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function
Enrollment
26 pts
Location
United States
Sponsor
Pfizer
NCT06985615 Phase 1
Recruiting
A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement
Enrollment
40 pts
Location
China
Sponsor
Hangzhou Zhongmei Huadong Phar...